Micafungin sodium and Enterococcal infection - a phase IV clinical study of FDA data

Summary:

Enterococcal infection is reported as a side effect among people who take Micafungin sodium (micafungin sodium), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Tacrolimus, and have Bone marrow conditioning regimen.

The phase IV clinical study analyzes which people have Enterococcal infection when taking Micafungin sodium. It is created by eHealthMe based on reports of 1,784 people who have side effects when taking Micafungin sodium from the FDA, and is updated regularly.

What is Micafungin sodium?

Micafungin sodium has active ingredients of micafungin sodium. eHealthMe is studying from 1,787 Micafungin sodium users. Check the latest studies of Micafungin sodium.

What is Enterococcal infection?

Enterococcal infection is found to be associated with 626 drugs and 760 conditions by eHealthMe. Check the latest studies of Enterococcal infection.

On Jul, 29, 2026

1,784 people reported to have side effects when taking Micafungin sodium.
Among them, 23 people (1.29%) have Enterococcal infection.

Could Micafungin sodium cause Enterococcal infection?

Among these 23 people:

How long have people been on Micafungin sodium when they have Enterococcal infection? *

What is the gender of people who have Enterococcal infection when taking Micafungin sodium? *

female: 28.57 %
male: 71.43 %

What is the age of people who have Enterococcal infection when taking Micafungin sodium? *

What are other drugs people take besides Micafungin sodium? *

Tacrolimus: 11 people, 47.83%
Methotrexate: 10 people, 43.48%
Prednisolone: 9 people, 39.13%
Methylprednisolone Sodium Succinate: 9 people, 39.13%
Etoposide: 8 people, 34.78%
Vincristine Sulfate: 8 people, 34.78%
Sulfamethoprim: 8 people, 34.78%
Hydrocortisone Sodium Succinate: 8 people, 34.78%
Zovirax: 7 people, 30.43%
Ceftriaxone: 7 people, 30.43%

What are other side effects people have besides Enterococcal infection? *

Diarrhea: 14 people, 60.87%
Pneumonia: 12 people, 52.17%
Febrile Neutropenia (fever with reduced white blood cells): 10 people, 43.48%
Infection: 8 people, 34.78%
Pain: 8 people, 34.78%
Nausea (feeling of having an urge to vomit): 8 people, 34.78%
Melaena (the passage of black, tarry stools): 8 people, 34.78%
Pancreatitis (inflammation of pancreas): 7 people, 30.43%
Memory Loss: 7 people, 30.43%
Depression: 7 people, 30.43%

What are the existing conditions these people have? *

Bone Marrow Conditioning Regimen: 11 people, 47.83%
White Blood Cell Count Abnormal: 5 people, 21.74%
Oral Candidiasis (fungal infection of mouth): 5 people, 21.74%
Ewing's Sarcoma Recurrent (malignant small, round, blue cell tumour- recurrent): 5 people, 21.74%
Graft Versus Host Disease In Skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin): 2 people, 8.70%
Bacteraemia (presence of bacteria in the blood): 2 people, 8.70%
Aplastic Anemia: 2 people, 8.70%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 8.70%
Malignant Melanoma (skin cancer rises from melancytes): 1 person, 4.35%
Liver Transplant Rejection (failure of liver transplant): 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Micafungin sodium and have Enterococcal infection?

- Check whether Enterococcal infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Micafungin sodium:

Micafungin sodium (1,787 reports)

Browse all side effects of Micafungin sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Enterococcal infection:

Enterococcal infection (626 drugs)

Browse all the conditions that are associated with Enterococcal infection:

Enterococcal infection (760 conditions)

Related publications that referenced our studies

Cheng HI, Chen TH, Chung TC, Lee HY, Yu CY, "Micafungin-Induced Hyperbilirubinemia: A Case Report", 臺灣臨床藥學雜誌, 2014 Jun .
Cheng HI, Chen TH, Chung TC, Lee HY, Yu CY, "Micafungin-Induced Hyperbilirubinemia: A Case Report", 臺灣臨床藥學雜誌, 2014 Jun .

How the study uses the data?

The study uses data from the FDA. It is based on micafungin sodium (the active ingredients of Micafungin sodium) and Micafungin sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.